Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rancho Santa Margarita, CA
NPI
1609222090
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
30511 Avenida de Las Flores # 1064
Rancho Santa Margarita, CA, 92688
Phone (858) 933-5050
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
294 services
Medicare patients, 2024
88
Average age 68
Drug cost, 2024
$1.7M
4,922 prescriptions
Company payments, 2025
$135
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Afshin Hamidi was code 99214 (office e&m - established), 131 times for 56 patients. In total Afshin Hamidi billed 294 services in 19 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 131 | 56 | $75.59 | $9,902 |
| 99215 Office E&M - Established | Office | 58 | 21 | $136.80 | $7,934 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 33 | 12 | $27.15 | $896 |
By year: 2022 $11K for 127 services; 2023 $22K for 296 services; 2024 $24K for 294 services.
Medicare prescription drug claims, 2024
In 2024, the drug Afshin Hamidi prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 611 prescriptions and refills. In total Afshin Hamidi wrote 4,922 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 611 | 660 | 86 | $681K |
| Pioglitazone Hcl Generic | 399 | 1,037 | 109 | $4,319 |
| Metformin Hcl Generic | 376 | 903 | 105 | $2,460 |
| Atorvastatin Calcium Generic | 326 | 776 | 92 | $3,598 |
| Jardiance Empagliflozin | 313 | 506 | 67 | $279K |
| Losartan Potassium Generic | 210 | 554 | 64 | $1,748 |
| Rosuvastatin Calcium Generic | 205 | 577 | 61 | $3,502 |
| Ozempic Semaglutide | 136 | 182 | 38 | $164K |
| Levothyroxine Sodium Generic | 131 | 353 | 38 | $1,810 |
| Hydrochlorothiazide Generic | 121 | 300 | 41 | $654 |
| Fenofibrate Fenofibrate Nanocrystallized | 88 | 208 | 24 | $2,451 |
| Amlodipine Besylate Generic | 88 | 233 | 31 | $512 |
| Ezetimibe Generic | 78 | 196 | 27 | $1,993 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 78 | 135 | 25 | $38K |
| Dapagliflozin Dapagliflozin Propanediol | 77 | 137 | 18 | $58K |
Brand drugs: 1,769 claims; generic drugs: 3,014 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Afshin Hamidi $135 ($135 in general payments such as food, travel and fees) from 2 companies. The largest payer was Recordati_rare_diseases_inc. with $111.
| Company | Payments | Amount |
|---|---|---|
| Recordati_rare_diseases_inc. | 4 | $111 |
| Amgen Inc. AMGN | 1 | $23.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.